We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.19%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.12B
AUM Growth
+$146M
Cap. Flow
-$6.04M
Cap. Flow %
-0.54%
Top 10 Hldgs %
16.93%
Holding
462
New
136
Increased
57
Reduced
41
Closed
111

Sector Composition

Rank Sector Weight
1 Financials 29.94%
2 Healthcare 10.97%
3 Technology 7.15%
4 Communication Services 3.95%
5 Industrials 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXACU
101
DELISTED
Oxbridge Acquisition Corp. Unit
OXACU
$3.14M 0.28%
+306,294
New +$3.1M
FATH
102
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$3.13M 0.28%
+15,896
New +$3.13M
PPHPU
103
DELISTED
PHP Ventures Acquisition Corp. Units
PPHPU
$3.06M 0.27%
+299,148
New +$3.04M
GACQW
104
DELISTED
Global Consumer Acquisition Corp. Warrant
GACQW
$3.01M 0.27%
+304,405
New +$154K
MOND
105
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$3M 0.27%
307,453
EJFA
106
DELISTED
EJF Acquisition Corp. Class A Ordinary Share
EJFA
$2.96M 0.26%
300,000
ELIQ
107
DELISTED
Electriq Power Holdings, Inc.
ELIQ
$2.96M 0.26%
300,000
PGRW
108
DELISTED
Progress Acquisition Corp. Class A Common Stock
PGRW
$2.94M 0.26%
299,900
-100
-0% -$972
TZPS
109
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
$2.93M 0.26%
299,997
SLAM
110
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$2.92M 0.26%
300,000
CPTK
111
DELISTED
Crown PropTech Acquisitions
CPTK
$2.92M 0.26%
300,000
ITQ
112
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$2.92M 0.26%
300,000
SPTK
113
DELISTED
SportsTek Acquisition Corp. Class A Common Stock
SPTK
$2.92M 0.26%
300,000
OSTR
114
DELISTED
Oyster Enterprises Acquisition Corp. Class A Common Stock
OSTR
$2.92M 0.26%
300,000
KRNL
115
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
$2.92M 0.26%
300,000
BIOT
116
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$2.92M 0.26%
300,000
MIT
117
DELISTED
Mason Industrial Technology, Inc.
MIT
$2.92M 0.26%
300,000
HIII
118
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
$2.92M 0.26%
300,000
KIII
119
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
$2.92M 0.26%
300,000
BITE
120
DELISTED
Bite Acquisition Corp.
BITE
$2.92M 0.26%
300,000
SOC icon
121
Sable Offshore Corp
SOC
$794M
$2.92M 0.26%
300,000
TWLV
122
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
$2.92M 0.26%
300,000
MDAI icon
123
Spectral AI
MDAI
$49.6M
$2.91M 0.26%
300,000
NRAC
124
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$2.91M 0.26%
300,000
FSNB
125
DELISTED
Fusion Acquisition Corp. II
FSNB
$2.91M 0.26%
300,000

Similar funds

Mangrove Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Mangrove Partners held 462 positions worth $1.12B, up 15% from $971M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Mangrove Partners's Q3 2021 filing shows 136 new, 57 increased, 41 reduced and 111 closed positions. Its largest new stake was Biogen: 45,872 shares worth $13M. The largest sale was Macquarie Infrastructure Holdings, LLC, an estimated $32.2M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 37% a quarter earlier, followed by Healthcare and Technology.

  • Mangrove Partners's largest Q3 2021 buy was Biogen: 45,872 shares worth $13M.
  • Mangrove Partners added most to Travere Therapeutics in Q3 2021, an estimated $6.57M increase.
  • Mangrove Partners's biggest Q3 2021 reduction was Pershing Square Tontine Holdings, Ltd., cutting an estimated $12.8M.
  • Mangrove Partners fully exited Macquarie Infrastructure Holdings, LLC in Q3 2021, selling an estimated $32.2M.
  • Mangrove Partners's ten largest holdings make up 17% of its $1.12B portfolio in Q3 2021.
  • Mangrove Partners opened 136 new positions and closed 111 in Q3 2021.
  • Mangrove Partners's portfolio value rose 15% quarter-over-quarter to $1.12B.

Based on Mangrove Partners's 13F filing for Q3 2021, filed 15 Nov 2021.